Gene therapy replaces a faulty gene or adds a new gene in an attempt to cure disease or improve your body's ability to fight disease. Gene therapy holds promise for treating a wide range of diseases, such as cancer, cystic fibrosis, heart disease, diabetes, hemophilia and AIDS.
Learn about gene therapy, which replaces a faulty gene or adds a new gene in an attempt to cure disease or improve your body's ability to fight disease. ... Research and Clinical TrialsSee how Mayo Clinic research and clinical trials advance the science of medicine and improve patient care. Explore now. Education.
The Virology and Gene Therapy track within the Ph.D. Program at Mayo Clinic Graduate School of Biomedical Science offers a highly productive, interactive research environment for you to develop as an independent investigator.
About The Musculoskeletal Gene Therapy Research Lab at Mayo Clinic studies gene transfer to treat joint diseases such as osteoarthritis and to promote tissue regeneration after musculoskeletal injuries.
Christopher H. Evans, Ph.D., director of the Rehabilitation Medicine Research Center at Mayo Clinic's campus in Rochester, Minnesota, and Carmen M. Terzic, M.D., Ph.D., chair of Physical Medicine and Rehabilitation, discuss gene therapy for cartilage regeneration at the 2015 Fourth Annual Symposium on Regenerative Rehabilitation.
Harnessing genes and viruses to infect and kill tumor cells offers a promising step forward in cancer treatment. Researchers in the Gene and Virus Therapy Program of the Mayo Clinic Cancer Center are finding novel ways to manipulate these potent cancer fighters and expand treatment options for ...
Mayo’s research. As an example of the potential, David Deyle, M.D., of the Mayo Clinic Department of Clinical Genomics and Center for Individualized Medicine Clinomics Program, is using gene therapy in his research into possible treatments for osteogenesis imperfecta, also known as brittle bone disease. People with this devastating rare ...
This project aims to develop a lentivirus-mediated gene therapy to treat multiple inborn errors of liver metabolism, with the research in HT1 serving as a model for future studies of other rare liver diseases. Dr. Lillegard is a supplemental consultant at Mayo Clinic and a pediatric general and thoracic surgeon at Children's Minnesota.
CAR T-cell therapy, which seeks to harness the power of the immune system by genetically modifying cells to attack cancer, is a new form of gene therapy. CAR T, a form of gene therapy currently used in patient care at Mayo Clinic, is offered as treatment for patients with B-cell leukemias and lymphomas.
Faculty for the Virology and Gene Therapy track within the Ph.D. Program at Mayo Clinic Graduate School of Biomedical Science.